Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma
Article in Cancer (April 2024)
The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.
Article in Cancer (April 2024)
Article in Immunology (March 2024)
Article in Heliyon (March 2024)